Enhancing NIH Research on Autoimmune Disease (2022)

Chapter: Appendix C: Open Session Agendas

Previous Chapter: Appendix B: List of Autoimmune Diseases
Suggested Citation: "Appendix C: Open Session Agendas." National Academies of Sciences, Engineering, and Medicine. 2022. Enhancing NIH Research on Autoimmune Disease. Washington, DC: The National Academies Press. doi: 10.17226/26554.

Appendix C

Open Session Agendas

Wednesday, November 18, 2020, 1:30 – 4:00 p.m. (ET)

Web Conference

Open Session Agenda

1:30 – 1:45Welcome and introductions
Bernard Rosof, M.D., Committee Chair, and Committee
1:45 – 2:00Sponsor charge to the committee
Ellen Goldmuntz, M.D., Ph.D., Section Chief, Rheumatologic Autoimmune Disease Section, National Institute of Allergy and Infectious Diseases (NIAID), NIH
2:00 – 2:10Study background
Alex Keenan, Clerk, Subcommittee on Labor, Health and Human Services, Education and Related Agencies, Senate Committee on Appropriations (Minority Staff)
Suggested Citation: "Appendix C: Open Session Agendas." National Academies of Sciences, Engineering, and Medicine. 2022. Enhancing NIH Research on Autoimmune Disease. Washington, DC: The National Academies Press. doi: 10.17226/26554.
2:10 – 2:25Overview of NIH Institutes and Centers and funding structure
James McNamara, M.D., Section Chief, Autoimmunity and Mucosal Immunology Branch, Division of Allergy, Immunology and Transplantation, NIAID, NIH
2:25 – 3:05State of autoimmune diseases in the U.S.
Virginia Ladd, Founder, Past President Emerita, Advisor to the President, American Autoimmune Related Diseases Association
3:05 – 3:45Autoimmune disease research in the U.S.
Jane Buckner, M.D., President, Benaroya Research Institute at Virginia Mason
3:45 – 4:00Q & A
4:00Adjourn

Open Session
February 1 – 2, 2021
Full Schedule in Eastern Time
Web Conference

Meeting Agenda1

February 1, 2021, 1:15 – 4:40p

OPEN SESSION

1:15 – 1:30Open Session Begins
1:30 – 1:45Welcome and introductions
Bernard Rosof, M.D., Committee Chair and Committee
1:45 – 2:10NIH Extramural Grant Review Process – Center for Scientific Review (CSR)
Deborah Hodge, Ph.D., Scientific Review Officer, Division of Physiological and Pathological Sciences, CSR, NIH

___________________

1 All presentations and slides for open sessions can be found at https://www.nationalacademies.org/our-work/assessment-of-nih-research-on-autoimmune-diseases#sectionPastEvents.

Suggested Citation: "Appendix C: Open Session Agendas." National Academies of Sciences, Engineering, and Medicine. 2022. Enhancing NIH Research on Autoimmune Disease. Washington, DC: The National Academies Press. doi: 10.17226/26554.
2:10 – 2:35Advancing Women’s Health Research at NIH
Lisa Begg, Dr.P.H., R.N., Senior Research Program Officer, Office of Research on Women’s Health (ORWH), NIH
2:35 – 2:45Break
2:45 – 2:55Panel Discussion: NIH Autoimmune Research across ICs
Introductions – Committee Moderator
2:55 – 3:10James McNamara, M.D., Section Chief, Autoimmunity and Mucosal Immunology Branch, Division of Allergy, Immunology and Transplantation, NIAID, NIH
3:10 – 3:25Marie Mancini, Ph.D., Program Director, Systemic Autoimmune Disease Biology Program, National Institute of Arthritis and Musculoskeletal and Skin Disease (NIAMS), NIH
3:25 – 3:40Ursula Utz, Ph.D., Program Director, Neuroimmunology, Autoimmunity, Neurovirology, Multiple Sclerosis, National Institute of Neurological Disorders and Stroke (NINDS), NIH
3:40 – 3:55Ruth Kirby, Clinical Trials Specialist, National Heart, Lung, and Blood Institute (NHLBI), NIH
3:55 – 4:30Discussion
4:30Adjourn

February 2, 2021, 1:00 – 3:15p

OPEN SESSION

1:00 – 1:05Welcome and Introductions
Bernard Rosof, M.D., Committee Chair
1:05 – 1:30Advances and Opportunities in Multiple Sclerosis
Nicholas LaRocca, Ph.D., Consultant, National Multiple Sclerosis Society (NMSS)
Suggested Citation: "Appendix C: Open Session Agendas." National Academies of Sciences, Engineering, and Medicine. 2022. Enhancing NIH Research on Autoimmune Disease. Washington, DC: The National Academies Press. doi: 10.17226/26554.
1:30 – 1:55Advances and Opportunities in Autoimmune Arthritis
Emily von Scheven, M.D., M.A.S., Chief of Rheumatology, UCSF Benioff Children’s Hospital
Mary K. Crow, M.D., Director, Autoimmunity and Inflammation Research Program; Co-Director, Mary Kirkland Center for Lupus Research at the HSS Research Institute
1:55 – 2:20Advances and Opportunities in Type 1 Diabetes
Sanjoy Dutta, Ph.D., Vice President for Research, Juvenile Diabetes Research Foundation
2:20 – 2:45Advances and Opportunities in Inflammatory Bowel Disease
Caren Heller, M.D., M.B.A., Chief Scientific Officer, Crohn’s & Colitis Foundation
2:45 – 3:15Discussions
3:15Adjourn

March 4 – 5, 2021

Public Session

Web Conference

Meeting Agenda

Thursday, March 4, 2021, 1:30 – 5:30 pm (EST)

1:30Public Session Begins
1:30 – 1:45Welcome and introductions
Bernard Rosof, M.D., Committee Chair and Committee
Suggested Citation: "Appendix C: Open Session Agendas." National Academies of Sciences, Engineering, and Medicine. 2022. Enhancing NIH Research on Autoimmune Disease. Washington, DC: The National Academies Press. doi: 10.17226/26554.
NIH Intramural Research for Autoimmune Diseases
1:45 – 2:10Daniel Kastner, M.D., Ph.D., Scientific Director, Division of Intramural Research, NHGRI, NIH
2:10 – 2:35Karyl S. Barron, M.D., Deputy Director, Division of Intramural Research, NIAID, NIH
2:35 – 3:00Lisa G. Rider, M.D., Acting Head, Environmental Autoimmunity Group, Clinical Research Branch, NIEHS, NIH
3:00 – 3:25John O’Shea, Ph.D., Scientific Director and Director of Intramural Research Program, NIAMS, NIH
3:25 – 3:40Break
NIH Extramural Research for Autoimmune Diseases Across ICs
3:40 – 4:05Lisa Spain, Ph.D., Program Director, Division of Diabetes, Endocrinology, and Metabolic Diseases, NIDDK, NIH
4:05 – 4:30Michael C. Humble, Ph.D., Program Administrator, Genes, Environment and Health Branch, Division of Extramural Research and Training, NIEHS, NIH
4:30 – 4:55Nishadi Rajapakse, Ph.D., M.H.S., Program Director, Transdisciplinary Collaborative Centers on Precision Medicine,
Centers of Excellence on Environmental Health Disparities, Division of Scientific Programs, NIMHD, NIH
4:55 – 5:30Discussion
5:30Adjourn
Suggested Citation: "Appendix C: Open Session Agendas." National Academies of Sciences, Engineering, and Medicine. 2022. Enhancing NIH Research on Autoimmune Disease. Washington, DC: The National Academies Press. doi: 10.17226/26554.

Friday, March 5, 2021, 1:00 – 3:15 pm (EST)

1:00Public Session Begins
1:00 – 1:05Welcome and Introductions
Bernard Rosof, M.D., Committee Chair
1:05 – 1:30Advances and Opportunities in Lupus
Judith A. James, M.D, Ph.D, Vice President of Clinical Affairs,
Member & Chair, Arthritis & Clinical Immunology, Oklahoma Medical Research Foundation;
Associate Vice Provost for Clinical and Translational Science,
Professor of Medicine, Professor of Pathology, Oklahoma University Health Sciences Center
1:30 -1:55Advances and Opportunities in Dermatological Autoimmune Diseases
Victoria P. Werth, M.D., Professor of Dermatology at the Hospital of the University of Pennsylvania and the Veteran’s Administration (V.A.) Medical Center; Chief, Dermatology, Philadelphia V.A. Hospital
1:55 – 2:20Advances and Opportunities in Autoimmune Thyroid Diseases
Yaron Tomer M.D., Anita and Jack Saltz Chair in Diabetes Research
Professor and Chair, Department of Medicine
Albert Einstein College of Medicine, Montefiore Medical Center
2:20 – 2:45Advances and Opportunities in Primary Biliary Cholangitis
Mark Pedersen, M.D., Assistant Professor of Medicine, Division of Digestive and Liver Disease, University of Texas Southwestern Medical Center
2:45 – 3:15Discussion
3:15Adjourn
Suggested Citation: "Appendix C: Open Session Agendas." National Academies of Sciences, Engineering, and Medicine. 2022. Enhancing NIH Research on Autoimmune Disease. Washington, DC: The National Academies Press. doi: 10.17226/26554.
Page 457
Suggested Citation: "Appendix C: Open Session Agendas." National Academies of Sciences, Engineering, and Medicine. 2022. Enhancing NIH Research on Autoimmune Disease. Washington, DC: The National Academies Press. doi: 10.17226/26554.
Page 458
Suggested Citation: "Appendix C: Open Session Agendas." National Academies of Sciences, Engineering, and Medicine. 2022. Enhancing NIH Research on Autoimmune Disease. Washington, DC: The National Academies Press. doi: 10.17226/26554.
Page 459
Suggested Citation: "Appendix C: Open Session Agendas." National Academies of Sciences, Engineering, and Medicine. 2022. Enhancing NIH Research on Autoimmune Disease. Washington, DC: The National Academies Press. doi: 10.17226/26554.
Page 460
Suggested Citation: "Appendix C: Open Session Agendas." National Academies of Sciences, Engineering, and Medicine. 2022. Enhancing NIH Research on Autoimmune Disease. Washington, DC: The National Academies Press. doi: 10.17226/26554.
Page 461
Suggested Citation: "Appendix C: Open Session Agendas." National Academies of Sciences, Engineering, and Medicine. 2022. Enhancing NIH Research on Autoimmune Disease. Washington, DC: The National Academies Press. doi: 10.17226/26554.
Page 462
Next Chapter: Appendix D: Epidemiology: Select Diseases
Subscribe to Emails from the National Academies
Stay up to date on activities, publications, and events by subscribing to email updates.